Micromines (MICRO)

gBio frens

Was scrolling through upcoming @BioProtocol launches and one name just wouldn’t leave my head: @join_microdao
AMR is on track for 39M deaths and $100T in losses by 2050, yet it gets <1% of R&D funding. That’s just insane

MicroDAO’s approach hits different: AMR marketplace, IP‑NFTs for antibiotic and vaccine research, community‑funded tools and diagnostics, all eventually governed by $MICRO on Bio. Not vibes, actual global health infra being built in the open

Feels like the DeSci play people only notice in hindsight #DeSci #BioProtocol #MicroDAO

Watching @BioProtocol line up projects like @join_microdao makes it clear this isn’t just another hype cycle, it’s a pipeline

MicroDAO using IP tokens, an AMR marketplace and a $MICRO governance loop to tackle antibiotic resistance on-chain is miles ahead of usual “grant → paper → nowhere” research. Add BioXP incentives and launchpad access, and you suddenly have retail + scientists co-steering life-or-death science instead of waiting on pharma boardrooms

If this model works for AMR, what
stops it from eating half of biomedical R&D?

MicroDAO on @BioProtocol Launchpad

The antimicrobial resistance (AMR) crisis could cause 39M deaths & $100T in costs by 2050, yet gets <1% of R&D funding.

@join_microdao aims to change that:
- Predict & Validate: AI + genomic data to forecast AMR hotspots
- Prevent: antibiotic stewardship & behavioral interventions
- Cure: drive R&D for vaccines, diagnostics & new antibiotics

Model:
- Fundraising via BIO Launchpad (Curation → Auction → Liquidity)
- Marketplace for AMR tools/data → sustainable revenue
- $MICRO token empowers contributors & funds research

Team: AMR scientists, policy experts & blockchain devs

📅 Roadmap:

Q3/2025: Marketplace v1 + Impact Calculator
Q4/2025: Pathogen Solution Marketplace
Q1/2026: $MICRO TGE

Why it matters: The first BioDAO focused on AMR, tackling a global health crisis with a community-driven & sustainable model.

#BioProtocol #BioDAO #DeSci #MicroDAO #BIO